FY25 consensus $5.14. Abbott (ABT) reaffirms previously provided full-year 2025 organic sales growth guidance of 7.5% to 8.0%, excluding COVID-19 testing-related sales, or 6.0% to 7.0%, when including COVID-19 testing-related sales. Abbott also reaffirms the midpoint of the previously provided full-year 2025 adjusted diluted EPS guidance range and narrows the range to $5.12 to $5.18, which reflects double-digit growth at the midpoint.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Options Volatility and Implied Earnings Moves Today, October 15, 2025
- Notable companies reporting before tomorrow’s open
- Options Volatility and Implied Earnings Moves This Week, October 14 – October 17, 2025
- ABT Earnings this Week: How Will it Perform?
- Align downgraded, NetEase upgraded: Wall Street’s top analyst calls